Ningbo Sanxing Medical Electric Co.,Ltd. (SHA:601567)
China flag China · Delayed Price · Currency is CNY
20.06
-0.68 (-3.28%)
Apr 30, 2026, 3:00 PM CST

SHA:601567 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
13,74614,14014,38411,2618,9396,911
Other Revenue
221.02221.02216.26201.71158.82112.31
13,96714,36114,60011,4639,0987,023
Revenue Growth (YoY)
-8.15%-1.64%27.38%25.99%29.55%-0.98%
Cost of Revenue
10,29410,4489,5847,6006,4875,259
Gross Profit
3,6733,9135,0173,8622,6111,764
Selling, General & Admin
1,9251,9291,9141,6261,188845.78
Research & Development
599.41598.27515.58463.77320.81285.94
Other Operating Expenses
9.9-14.67-71.8819.1123.3640.92
Operating Expenses
2,6132,5892,3822,1341,5221,215
Operating Income
1,0601,3232,6351,7291,089548.89
Interest Expense
-132.42-124.49-95-52.75-61.33-83.25
Interest & Investment Income
267.13257.25304.98342.58123.66239.61
Currency Exchange Gain (Loss)
139.42139.42-111.9440.9255-32.97
Other Non Operating Income (Expenses)
-117.91-33.48-31.01-30.67-17.4542.5
EBT Excluding Unusual Items
1,2161,5622,7022,0291,189714.77
Impairment of Goodwill
-355.86-355.86-13.6-8.68-9.49-1.79
Gain (Loss) on Sale of Investments
227.37245.13-177.13132.41-107.48103.7
Gain (Loss) on Sale of Assets
0.140.6-0.04-0.1-1.88-7.65
Asset Writedown
-3.94-8.01-11.31-1.671.57-4.59
Other Unusual Items
134.83134.83172.96111.4680.7842.38
Pretax Income
1,2191,5792,6732,2621,152846.81
Income Tax Expense
287.93330399.32341.26187.04139.2
Earnings From Continuing Operations
930.651,2492,2731,921965.01707.61
Minority Interest in Earnings
21.3225.12-13.72-17.1-16.89-17.57
Net Income
951.981,2742,2601,904948.12690.04
Net Income to Common
951.981,2742,2601,904948.12690.04
Net Income Growth
-60.08%-43.62%18.69%100.79%37.40%-27.83%
Shares Outstanding (Basic)
1,4151,4161,4121,4101,4151,380
Shares Outstanding (Diluted)
1,4151,4161,4121,4101,4151,380
Shares Change (YoY)
0.22%0.24%0.14%-0.35%2.54%-0.40%
EPS (Basic)
0.670.901.601.350.670.50
EPS (Diluted)
0.670.901.601.350.670.50
EPS Growth
-60.17%-43.75%18.52%101.49%34.00%-27.54%
Free Cash Flow
1,141831.91791.631,345818.7-96.3
Free Cash Flow Per Share
0.810.590.560.950.58-0.07
Dividend Per Share
1.1151.1150.8900.6500.3500.320
Dividend Growth
25.28%25.28%36.92%85.71%9.38%-8.57%
Gross Margin
26.30%27.25%34.36%33.69%28.70%25.11%
Operating Margin
7.59%9.22%18.05%15.08%11.97%7.82%
Profit Margin
6.82%8.87%15.48%16.61%10.42%9.83%
Free Cash Flow Margin
8.17%5.79%5.42%11.74%9.00%-1.37%
EBITDA
1,3771,6322,9111,9811,317744.1
EBITDA Margin
9.86%11.37%19.94%17.29%14.48%10.60%
D&A For EBITDA
317.1308.97276.45252.77228.7195.22
EBIT
1,0601,3232,6351,7291,089548.89
EBIT Margin
7.59%9.22%18.05%15.08%11.97%7.82%
Effective Tax Rate
23.63%20.90%14.94%15.09%16.23%16.44%
Revenue as Reported
13,96714,36114,60011,4639,0987,023
Advertising Expenses
-39.132.2118.0711.288.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.